Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
OPK Opko Health Inc
- Stocks
- Healthcare
- NASDAQ: OPK
Price (delayed)
$1.305
Market cap
$1.03B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.05
Enterprise value
$1.08B
Opko Health Inc. is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and
Highlights
Opko Health's EPS has soared by 86% YoY and by 38% from the previous quarter
The net income has soared by 85% year-on-year and by 27% since the previous quarter
Opko Health's quick ratio has soared by 96% YoY but it has decreased by 37% from the previous quarter
The debt has increased by 19% YoY but it has decreased by 2.2% QoQ
The gross profit has contracted by 16% YoY
The company's revenue fell by 14% YoY and by 3.3% QoQ
Key stats
What are the main financial stats of OPK
Market
Valuations
Earnings
Shares outstanding
793.05M
Market cap
$1.03B
Enterprise value
$1.08B
Price to earnings (P/E)
N/A
Price to book (P/B)
0.67
Price to sales (P/S)
1.27
EV/EBIT
19.82
EV/EBITDA
7.2
EV/Sales
1.57
Revenue
$689.41M
Gross profit
$219.06M
Operating income
-$147.76M
Net income
-$39M
EBIT
$54.67M
EBITDA
$150.51M
Free cash flow
-$205.98M
Per share
Balance sheet
Liquidity
EPS
-$0.05
EPS diluted
-$0.06
Free cash flow per share
-$0.31
Book value per share
$1.95
Revenue per share
$1.03
TBVPS
$1.61
Total assets
$2.13B
Total liabilities
$816.66M
Debt
$484.64M
Equity
$1.31B
Working capital
$441.75M
Debt to equity
0.37
Current ratio
2.49
Quick ratio
1.8
Net debt/EBITDA
0.32
Margins
Efficiency
Dividend
EBITDA margin
21.8%
Gross margin
31.8%
Net margin
-5.7%
Operating margin
-21.4%
Return on assets
-1.8%
Return on equity
-2.8%
Return on invested capital
6.2%
Return on capital employed
3%
Return on sales
7.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
OPK stock price
How has the Opko Health stock price performed over time
Intraday
3.57%
1 week
1.95%
1 month
-7.77%
1 year
3.57%
YTD
-11.22%
QTD
-21.39%
Financial performance
How have Opko Health's revenue and profit performed over time
Revenue
$689.41M
Gross profit
$219.06M
Operating income
-$147.76M
Net income
-$39M
Gross margin
31.8%
Net margin
-5.7%
The net income has soared by 85% year-on-year and by 27% since the previous quarter
The net margin has soared by 82% YoY and by 24% QoQ
The operating income has grown by 25% YoY and by 2.8% from the previous quarter
The gross profit has contracted by 16% YoY
Price vs fundamentals
How does OPK's price correlate with its fundamentals
Growth
What is Opko Health's growth rate over time
Valuation
What is Opko Health stock price valuation
P/E
N/A
P/B
0.67
P/S
1.27
EV/EBIT
19.82
EV/EBITDA
7.2
EV/Sales
1.57
Opko Health's EPS has soared by 86% YoY and by 38% from the previous quarter
The P/B is 41% below the 5-year quarterly average of 1.1 and 7% below the last 4 quarters average of 0.7
Opko Health's equity has increased by 4.7% YoY but it has decreased by 3.9% QoQ
The P/S is 18% below the 5-year quarterly average of 1.5 and 12% below the last 4 quarters average of 1.4
The company's revenue fell by 14% YoY and by 3.3% QoQ
Efficiency
How efficient is Opko Health business performance
Opko Health's ROS has soared by 127% YoY and by 52% from the previous quarter
OPK's ROIC has soared by 120% year-on-year and by 48% since the previous quarter
The ROA has soared by 85% YoY and by 28% from the previous quarter
The ROE has soared by 84% YoY and by 28% QoQ
Dividends
What is OPK's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for OPK.
Financial health
How did Opko Health financials performed over time
The company's total assets is 161% higher than its total liabilities
Opko Health's quick ratio has soared by 96% YoY but it has decreased by 37% from the previous quarter
Opko Health's current ratio has increased by 30% YoY but it has decreased by 27% from the previous quarter
The debt is 63% lower than the equity
The debt has increased by 19% YoY but it has decreased by 2.2% QoQ
The debt to equity is up by 12% year-on-year and by 2.8% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.